Article Information
History
- November 8, 2021.
Article Versions
- Version 1 (July 6, 2021 - 11:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Johanna Huoman, PhD1,*,
- Shumaila Sayyab, PhD1,*,
- Eirini Apostolou, PhD2,
- Lovisa Karlsson, MSc1,
- Lucas Porcile, BSc1,
- Muhammad Rizwan, MSc2,
- Sumit Sharma, PhD3,
- Jyotirmoy Das, PhD1,
- Anders Rosén, PhD2 and
- Maria Lerm, PhD1,**
- 1Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
- 2Division of Cell Biology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
- 3Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
- ↵**Corresponding author: Maria Lerm, PhD, Professor, Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Lab1, floor 12, Faculty of Medicine and Health Sciences, SE-581 85 Linköping, Sweden, Cell phone: +46-73-2707786, Visit us at: https://liu.se/en/employee/marle69, email: maria.lerm{at}liu.se
Posted November 08, 2021.
Epigenome-wide DNA methylation profiling of healthy COVID-19 recoverees reveals a unique signature in circulating immune cells
